Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., | ![]() Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ![]() Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | ||
Founding Date | Founding Date 2002 | Founding Date 1999 | Founding Date 2015 | Founding Date 2002 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Incheon, KR HQ | Locations Needham, US HQ | Locations Écully, FR HQ Cambridge, US | Locations TW HQ San Diego, US |
Employees | Employees 6301% increase | Employees 50 | Employees 402% decrease | Employees 124 |
Financial | ||||
Revenue (est.) | Revenue (est.) ₩2t (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) NT$41.5m (FY, 2023) |
Cost of goods | Cost of goods ₩1.4t (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods NT$115m (FY, 2023) |
Gross profit | Gross profit ₩664.7b (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit (NT$63.8m) (FY, 2023) |
Net income | Net income ₩147.2b (FY, 2022) | Net income ($55.2m) (FY, 2024) | Net income N/A | Net income (NT$1.3b) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 64.6m | Total funding raised $ 93.1m | Total funding raised N/A |
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View companyAmolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View companyOBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
View company